Retatrutide 20mg*10vials

描述

Core Features
Guaranteed Ultra-High Purity (≥99.0%): Produced using industry-leading automated high-throughput Solid-Phase Peptide Synthesis (SPPS) technology. Given Retatrutide’s complex, heterogeneous peptide chain structure, synthesis and purification present significant technical challenges. We employ a precise industrial-grade Reversed-Phase Preparative HPLC (RP-HPLC) process to rigorously eliminate by-products such as racemates, truncated chains, and mis-sequences. Each 20mg vial guarantees a baseline purity of ≥99.0%, providing a clean, interference-free matrix for your in vitro receptor affinity assays and in vivo animal metabolic model studies.
Synergistic Triple-Agonist Mechanism: Retatrutide is a standout molecule in metabolic research, capable of simultaneously targeting three key metabolic receptors with extremely high affinity: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). This unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving the synergistic downregulation of appetite, delayed gastric emptying, promotion of white adipose tissue browning, and upregulation of overall energy expenditure.
Advanced Cryo-Lyophilization Process: The 20mg peptide powder undergoes moisture sublimation at ultra-low temperatures (-80°C) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process not only ensures excellent reconstitution properties—allowing for rapid dissolution (within seconds) without precipitation or bubble formation when mixed with sterile water for injection or normal saline—but also stabilizes the molecule’s secondary structure. This significantly reduces the risk of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters | Parameter: Specification Details | Product Specification: 20 mg / Vacuum-Sealed Glass Vial | CAS Number: 2381089-83-2 | Molecular Formula: $\text{C}_{211}\text{H}_{342}\text{N}_{54}\text{O}_{68}$ | Molecular Weight: 4731.33 Da | Appearance: White to off-white sterile lyophilized powder or intact solid cake | Validation: Accompanied by original manufacturer HPLC purity chromatograms and MS molecular weight verification reports (one certificate per vial; supports digital traceability and batch verification).

❄️ Storage & Shipping Ironclad Policy
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in its unreconstituted state within an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$), ensuring protection from light and moisture while maintaining a high-vacuum seal. Storage in standard household appliances or office equipment lacking temperature logging capabilities is strictly prohibited. Given the large 20 mg vial size and the product’s susceptibility to degradation after reconstitution, researchers are strongly advised to aliquot and freeze the sample based on single-dose animal administration requirements; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” protocols. For the 20mg Retatrutide product, we utilize high-density, reinforced five-layer insulated foam boxes as the standard packaging. Shipments are expedited using high-capacity, phase-change gel packs to ensure that the peptide molecules maintain their complex spatial conformation in a stable, “locked-in” state while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Retatrutide 20mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or biopharmaceutical R&D centers (e.g., experiments on cell receptor binding affinity, monitoring of obesity interventions in rodent metabolic models, etc.). Any non-compliant use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent or performance-enhancing drug/stimulant in sports—is strictly prohibited. This platform enforces a rigorous multi-step review process regarding the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.